All ETFs

PHSRX

ETF

PHSRX · UNKNOWN · 37 holdings

55,03 €

▲ 1,04 € (1,93%)

Day Range

—

52-Week Range

—

Volume

—

Ouverture —

Moyenne 50J / 200J

—

Moyenne 50J / 200J

—

About PHSRX

No description available for this ETF.

Fund Details

Expense Ratio: —
Inception Date: —
Prev. Close: 53,99 €
Exchange: UNKNOWN
Currency: USD
Holdings As Of: Apr 10, 2026
Tracked Holdings: 70.3%
HHI Score: 444,76
Top Sector: Healthcare (78.552632%)

Performance

Low (17,1%) ↗ Recovering

▲ 1,12%

▼ -1,84%

▼ -1,57%

▲ 9,97%

YTD

▼ -1,26%

▲ 15,32%

▲ 11,96%

Positive 1W (+1.12%) after negative 1M (-1.84%) — trend may be reversing

Price History

Concentration Risk

56,31% Moderately Concentrated

Diversified Concentrated

The top 10 holdings represent 56,31% of the fund. This ETF is heavily concentrated — performance is largely driven by a few stocks.

Top Holdings Today

Weighted by position size

LLY

▲ 0,57%

ABBV

▲ 0,63%

UNH

▲ 0,09%

JNJ

▲ 0,60%

TMO

▲ 0,16%

BSX

▼ -2,15%

ABT

▼ -0,76%

BDX

▼ -0,28%

Weighted avg. of top holdings ▲ 0,06%

Sector Allocation

Healthcare

78,55%

Top 10 Holdings

56,31% of fund

LLY Eli Lilly & Co.

10,79%

ABBV AbbVie, Inc.

6,85%

UNH UnitedHealth Group, Inc.

6,70%

JNJ Johnson & Johnson

6,29%

AstraZeneca plc AstraZeneca plc

5,42%

TMO Thermo Fisher Scientific, Inc.

4,78%

Novartis AG Novartis AG

4,38%

BSX Boston Scientific Corp.

4,17%

ABT Abbott Laboratories

3,62%

BDX Becton Dickinson & Co.

3,31%

Other positions

0,42%

All Holdings (37)

Top 10: 56,31% of fund

#	Ticker	Name	Weight	Shares	Market Value
1	LLY	Eli Lilly & Co.	10,79%	214 700	157,28 M
2	ABBV	AbbVie, Inc.	6,85%	474 600	99,86 M
3	UNH	UnitedHealth Group, Inc.	6,70%	315 100	97,64 M
4	JNJ	Johnson & Johnson	6,29%	517 843	91,75 M
5	AstraZeneca plc	AstraZeneca plc	5,42%	496 120	79,09 M
6	TMO	Thermo Fisher Scientific, Inc.	4,78%	141 300	69,62 M
7	Novartis AG	Novartis AG	4,38%	504 886	63,90 M
8	BSX	Boston Scientific Corp.	4,17%	576 748	60,85 M
9	ABT	Abbott Laboratories	3,62%	397 400	52,72 M
10	BDX	Becton Dickinson & Co.	3,31%	249 900	48,23 M
11	MRK	Merck & Co., Inc.	2,88%	499 271	42,00 M
12	ASND	Ascendis Pharma A/S	2,78%	208 388	40,48 M
13	ISRG	Intuitive Surgical, Inc.	2,76%	84 900	40,18 M
14	INVA	Innoviva, Inc.	2,66%	1,90 M	38,72 M
15	MCK	McKesson Corp.	2,57%	54 500	37,42 M
16	GILD	Gilead Sciences, Inc.	2,38%	307 500	34,74 M
17	REGN	Regeneron Pharmaceuticals, Inc.	2,37%	59 600	34,61 M
18	Sanofi SA	Sanofi SA	1,98%	290 960	28,87 M
19	Argenx SE	Argenx SE	1,87%	38 299	27,27 M
20	DHR	Danaher Corp.	1,85%	130 700	26,90 M
21	CVS	CVS Health Corp.	1,84%	366 300	26,79 M
22	Roche Holding AG	Roche Holding AG	1,68%	75 090	24,49 M
23	CI	Cigna Group (The)	1,60%	77 600	23,35 M
24	HCA	HCA Healthcare, Inc.	1,57%	56 700	22,90 M
25	Putnam Funds Trust	Putnam Funds Trust	1,57%	22,87 M	22,87 M
26	CAH	Cardinal Health, Inc.	1,39%	136 300	20,28 M
27	Takeda Pharmaceutica	Takeda Pharmaceutical Co. Ltd.	1,16%	560 900	16,88 M
28	ALNY	Alnylam Pharmaceuticals, Inc.	1,11%	36 200	16,16 M
29	RYTM	Rhythm Pharmaceuticals, Inc.	1,10%	155 000	15,99 M
30	HUM	Humana, Inc.	1,09%	52 300	15,88 M
31	EHC	Encompass Health Corp.	1,09%	130 300	15,87 M
32	EssilorLuxottica SA	EssilorLuxottica SA	1,08%	51 382	15,67 M
33	Chugai Pharmaceutica	Chugai Pharmaceutical Co. Ltd.	0,83%	272 700	12,05 M
34	Soleno Therapeutics,	Soleno Therapeutics, Inc.	0,63%	136 626	9,25 M
35	LEGN	Legend Biotech Corp.	0,56%	234 286	8,14 M
36	ELVN	Enliven Therapeutics, Inc.	0,47%	338 800	6,87 M
37	Novo Nordisk A/S	Novo Nordisk A/S	0,43%	110 636	6,25 M